Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ reports

July 10 (Reuters) – Private equity firm Warburg Pincus is nearing a deal to acquire specialty pharmacy company PANTHERx Rare for more than $7 billion, including debt, the Wall Street Journal reported

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)